Search

Displaying results 9851 - 9860 of 10000 in total
  1. Drug

    GW-493838

    go.drugbank.com/drugs/DB12760
    Investigational

    GW493838 has been used in trials studying the treatment of Neuropathic Pain.

  2. Drug

    Clazakizumab

    go.drugbank.com/drugs/DB12849
    Investigational

    Clazakizumab has been used in trials studying the treatment of Rheumatoid Arthritis.

  3. Drug

    Pridopidine

    go.drugbank.com/drugs/DB11947
    Investigational

    Pridopidine has been used in trials studying the treatment of Huntington's Disease.

  4. Drug

    Evatanepag

    go.drugbank.com/drugs/DB12022
    Investigational

    Evatanepag has been used in trials studying the treatment of Tibial Fractures.

  5. Drug

    Anumigilimab

    go.drugbank.com/drugs/DB16359
    Investigational

    CSL324 is a fully human anti-G-CSFR antibody shown to have the ability to control G-CSF-mediated neutrophilia in cynomolgus macaques. … [A225626] It has potential applications in various inflammatory conditions such as cystic fibrosis, inflammatory bowel disease, rheumatoid arthritis, and vasculitis.[L27516]

  6. Drug

    JTK-853

    go.drugbank.com/drugs/DB13095
    Investigational

    JTK-853 has been used in trials studying the treatment of Hepatitis C Virus Infection, Response to Therapy of.

  7. Drug

    Dimepheptanol

    go.drugbank.com/drugs/DB19094
    Investigational

    Dimepheptanol is under investigation in clinical trial NCT00218127 (Treatment of Opioid/heroin Dependence: Comparison of Three Medication Dosing Regimens).

  8. Drug

    Nifekalant

    go.drugbank.com/drugs/DB16008
    Investigational

    Nifekalant is under investigation in clinical trial NCT03855826 (Evaluation of the Efficacy and Safety of Nifekalant Hydrochloride (NIF) Injection).

  9. Drug

    SAR445136

    go.drugbank.com/drugs/DB17708
    Investigational

    [A259063] It was formerly investigated for the treatment of beta-thalassemia, and it is currently being investigated for the treatment of sickle cell disease.[L46148] … It consists of autologous CD34+ hematopoietic stem precursor cells (HSPC) modified ex vivo by zinc finger nucleases (ZFN) that target the BCL11A gene erythroid-specific enhancer (ESE) to increase endogenous

  10. Drug

    Lapaquistat

    go.drugbank.com/drugs/DB16215
    Investigational

    Lapaquistat is under investigation in clinical trial NCT00256178 (Efficacy of Lapaquistat Acetate and Simvastatin in Subjects With Primary Dyslipidemia.).